CASI PHARMACEUTICALS, INC.: income tax expense or benefit

What this measure means

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Exact concept: us-gaap:IncomeTaxExpenseBenefit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2020-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• CASI PHARMACEUTICALS, INC.: total assets
• CASI PHARMACEUTICALS, INC.: total liabilities
• CASI PHARMACEUTICALS, INC.: stockholders equity
• CASI PHARMACEUTICALS, INC.: cash and cash equivalents
• CASI PHARMACEUTICALS, INC.: net income or loss
• CASI PHARMACEUTICALS, INC.: operating cash flow
• CASI PHARMACEUTICALS, INC.: capital expenditure payments
• CASI PHARMACEUTICALS, INC.: revenue
• CASI PHARMACEUTICALS, INC.: contract revenue excluding tax
• CASI PHARMACEUTICALS, INC.: financing cash flow
• CASI PHARMACEUTICALS, INC.: investing cash flow
• CASI PHARMACEUTICALS, INC.: retained earnings or deficit
• CASI PHARMACEUTICALS, INC.: basic weighted-average shares
• CASI PHARMACEUTICALS, INC.: diluted weighted-average shares
• CASI PHARMACEUTICALS, INC.: basic earnings per share
• CASI PHARMACEUTICALS, INC.: diluted earnings per share
• CASI PHARMACEUTICALS, INC.: net property, plant and equipment
• CASI PHARMACEUTICALS, INC.: share-based compensation expense
• CASI PHARMACEUTICALS, INC.: operating income or loss
• CASI PHARMACEUTICALS, INC.: current assets
• CASI PHARMACEUTICALS, INC.: interest expense
• CASI PHARMACEUTICALS, INC.: current liabilities
• CASI PHARMACEUTICALS, INC.: current accounts payable
• CASI PHARMACEUTICALS, INC.: net finite-lived intangible assets
• CASI PHARMACEUTICALS, INC.: net current accounts receivable
• CASI PHARMACEUTICALS, INC.: net inventory
• CASI PHARMACEUTICALS, INC.: gross profit
• CASI PHARMACEUTICALS, INC.: research and development expense

Inspect the source

Entity

CASI PHARMACEUTICALS, INC. / CIK 0001962738

Captured

2026-09-21T17:42:09.472Z

SEC response SHA-256

78b89df174c6f9978737a0e5b9c720225b15e6986d71b940a898352051937380

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001962738.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))